Kang S, Kim SB. Response to letter to the editor re: Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy. Eur J Cancer 2022 Dec 16:S0959-8049(22)01764-6. doi: 10.1016/j.ejca.2022.
PMID: 36529603